Letter: Enhancing HCC Surveillance: GES Score Represents an Innovative Simple Effective Tool for Risk Stratification, Patient Safety and Reduced Anxiety—Authors' Reply

IF 6.6 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Gamal Shiha, Riham Soliman
{"title":"Letter: Enhancing HCC Surveillance: GES Score Represents an Innovative Simple Effective Tool for Risk Stratification, Patient Safety and Reduced Anxiety—Authors' Reply","authors":"Gamal Shiha,&nbsp;Riham Soliman","doi":"10.1111/apt.18494","DOIUrl":null,"url":null,"abstract":"<p>We would like to express our appreciation to Dr. Gueye, World Hepatitis Alliance Afro Regional Board Member and Honour President of Saafara Hépatites Sénégal, for his insightful letter on the advantages of the General Evaluation Score (GES) in hepatocellular carcinoma (HCC) surveillance [<span>1</span>].</p><p>We agree with him that the GES score simplicity and practicality as a bedside tool make it accessible and easy to use in clinical practice [<span>2, 3</span>]. The ability to individualise surveillance using readily available routine blood tests, without reliance on costly or uncommon serum biomarkers that are not regularly performed in clinical practice [<span>4</span>], is a significant advantage. The low cost or no cost of the GES score, derived from routine laboratory tests that are already part of standard clinical care, ensures its practicality for widespread implementation, especially in developing countries where public health funds are limited.</p><p>The emphasis on reducing patient anxiety through tailored surveillance intervals further underscores the patient-centred approach of the GES scoring system. High-risk patients benefit from more frequent monitoring, ensuring timely intervention, while low-risk patients avoid unnecessary procedures, minimising their physical, emotional and financial burdens. I fully support initiatives advocating for its broader application and look forward to further studies affirming its value in diverse patient populations.</p><p>The authors' declarations of personal and financial interests are unchanged from those in the original article [<span>5</span>].</p><p><b>Gamal Shiha:</b> conceptualization, investigation, writing – review and editing, project administration, supervision. <b>Riham Soliman:</b> writing – original draft, methodology, data curation.</p><p>This article is linked to Shiha et al papers. To view these articles, visit https://doi.org/10.1111/apt.18291 and https://doi.org/10.1111/apt.18434.</p>","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":"61 5","pages":"913-914"},"PeriodicalIF":6.6000,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.18494","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/apt.18494","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

We would like to express our appreciation to Dr. Gueye, World Hepatitis Alliance Afro Regional Board Member and Honour President of Saafara Hépatites Sénégal, for his insightful letter on the advantages of the General Evaluation Score (GES) in hepatocellular carcinoma (HCC) surveillance [1].

We agree with him that the GES score simplicity and practicality as a bedside tool make it accessible and easy to use in clinical practice [2, 3]. The ability to individualise surveillance using readily available routine blood tests, without reliance on costly or uncommon serum biomarkers that are not regularly performed in clinical practice [4], is a significant advantage. The low cost or no cost of the GES score, derived from routine laboratory tests that are already part of standard clinical care, ensures its practicality for widespread implementation, especially in developing countries where public health funds are limited.

The emphasis on reducing patient anxiety through tailored surveillance intervals further underscores the patient-centred approach of the GES scoring system. High-risk patients benefit from more frequent monitoring, ensuring timely intervention, while low-risk patients avoid unnecessary procedures, minimising their physical, emotional and financial burdens. I fully support initiatives advocating for its broader application and look forward to further studies affirming its value in diverse patient populations.

The authors' declarations of personal and financial interests are unchanged from those in the original article [5].

Gamal Shiha: conceptualization, investigation, writing – review and editing, project administration, supervision. Riham Soliman: writing – original draft, methodology, data curation.

This article is linked to Shiha et al papers. To view these articles, visit https://doi.org/10.1111/apt.18291 and https://doi.org/10.1111/apt.18434.

信函:加强HCC监测:GES评分是风险分层、患者安全和减少焦虑的一种创新、简单有效的工具
我们要感谢世界肝炎联盟非洲地区理事会成员兼Saafara hsamnsamac荣誉主席Gueye博士,他在信中深刻地阐述了通用评估评分(GES)在肝细胞癌(HCC)监测中的优势。我们同意他的观点,GES评分作为一种床边工具的简单性和实用性使其易于在临床实践中使用[2,3]。使用现成的常规血液检查进行个体化监测的能力,而不依赖于临床实践中不经常执行的昂贵或罕见的血清生物标志物,这是一个显著的优势。GES评分来自常规实验室检测,已成为标准临床护理的一部分,其成本低或免费,确保了其广泛实施的实用性,特别是在公共卫生资金有限的发展中国家。强调通过量身定制的监测间隔来减少患者焦虑,进一步强调了GES评分系统以患者为中心的方法。高风险患者受益于更频繁的监测,确保及时干预,而低风险患者避免不必要的程序,最大限度地减少他们的身体、情感和经济负担。我完全支持倡导其更广泛应用的倡议,并期待进一步的研究肯定其在不同患者群体中的价值。作者的个人和经济利益声明与原文b[5]没有变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.60
自引率
7.90%
发文量
527
审稿时长
3-6 weeks
期刊介绍: Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信